tirzepatide and cancer risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Patients taking GLP-1 receptor agonists

Tirzepatide is the active ingredient in Mounjaro and Zepbound, medications that are dual-action GLP-1/GIP antagonists that have been shown to help people lose an average of 25% of their body weight.* A Zealthy provider will review your healthcare assessment & prescribe Mounjaro, Zepbound, or compounded tirzepatide, if appropriate

General Project Funding - German Diabetes Association, EASD Rising Star Fellowship, Anna Wunderlich und Ernst Jhling Award

Timing your medication, staying well-hydrated during non-fasting periods, and choosing nutrient-dense foods when you eat will help support your body through fasting and medication effects

For now, oral Wegovy is the only oral GLP-1 you can actually start in the UK

Take the Next Step Today If your search for Ozempic in Georgetown has led you here for weight loss solutions, consider the effective alternatives like Wegovy, Oral Wegovy, Zepbound, and Foundayo

Clinicians should work in multidisciplinary teams and closely monitor conditions that could possibly worsen or relapse due to lowering glucocorticoid doses